Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Catalysis . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover the advanced asymmetric hydrogenation process for levo-nicotine. Achieve 99.7% optical purity with scalable, cost-effective pharmaceutical intermediate manufacturing.
Patent CN110234626A reveals a safer continuous process for optically active pyrrolidine pharmaceutical intermediates. Enhance supply chain reliability and reduce manufacturing costs.
Novel patent CN104370769B enables robust production of Saxagliptin intermediates with improved purity and supply chain stability for global pharmaceutical partners.
Patent CN112266381B details a cost-effective synthesis of Barosavir intermediates using early resolution, offering significant supply chain advantages for API manufacturers.
Patent CN111233829A details a mild asymmetric reduction method for high-purity nicotine, offering significant cost reduction in fine chemical manufacturing and scalable supply chain solutions.
Patent CN119306599A details a high-yield asymmetric hydrogenation route for Vaborbactam intermediates, offering significant cost reduction and supply chain reliability for global pharma manufacturers.
Patent CN103288876B details a novel chiral phosphamide synthesis. Discover cost reduction in fine chemical manufacturing and reliable supply chain solutions.
Patent CN104557851B reveals a novel catalytic route for Eliglustat intermediates. This report analyzes cost reduction in API manufacturing and supply chain reliability for pharmaceutical partners.
Novel chiral phase transfer catalyst enables high-purity S-2-6-dimethyl tyrosine production with significant cost reduction and scalable supply chain reliability for global pharmaceutical manufacturers.
Discover the advanced synthesis of NOBIN-type axial chiral biaryl compounds via patent CN116535329B. Offers high enantioselectivity, metal-free catalysis, and scalable manufacturing for global pharmaceutical supply chains.
Patent CN114149427A reveals a novel catalytic asymmetric route for non-neferitone intermediates, offering significant cost reduction and scalable manufacturing for global supply chains.
Patent CN105085189A details a robust aprotic solvent method for chiral alcohol synthesis, offering significant supply chain stability and cost reduction for pharmaceutical intermediates.
Patent CN101142164B details a cost-effective route to Synthon A using planar chiral diphosphine catalysts, offering high ee and scalability for API manufacturing.
Patent CN102731478A details a high-yield asymmetric oxidation route for Dexlansoprazole intermediates, offering superior optical purity and scalable manufacturing capabilities for global supply chains.
Patent CN104557867A reveals a high-purity Esomeprazole Sodium method. This report analyzes cost reduction and supply chain reliability for global buyers.
Patent CN104854071B details asymmetric hydrogenation for high-purity tocopherol precursors. Enhance supply chain reliability and reduce manufacturing costs significantly.
Patent CN112299962B reveals a novel supported chiral phosphoric acid catalyst for high-yield citral intermediate synthesis, offering significant cost reduction and supply chain reliability.
Patent CN104610226A reveals a novel asymmetric oxidation method for dexlansoprazole intermediates, offering high purity and scalable supply chain advantages for global pharmaceutical manufacturers.
Patent CN112225697B reveals a green chiral resolution method for chloroquine phosphate, offering high purity and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN115677546B reveals a novel chiral synthesis route for Florfenicol intermediates, offering higher yields and eliminating toxic copper waste for reliable supply chains.